Organogenesis Holdings Inc. provided earnings guidance for the year ending December 31, 2023. For the period, the company expects Net revenue between $433 million and $446 million, representing a decrease of approximately 1% to 4% year-over-year, as compared to net revenue of $450.9 million for the year ended December 31, 2022. Net income between $4 million and $9 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 USD | +32.89% | +21.69% | -25.92% |
05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
05-09 | Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.92% | 402M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023